Charles Schwab’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-224,083
Closed -$40.3M 3098
2017
Q3
$40.3M Buy
224,083
+11,020
+5% +$1.98M 0.04% 506
2017
Q2
$22.1M Buy
213,063
+22,589
+12% +$2.34M 0.02% 791
2017
Q1
$15M Buy
190,474
+17,132
+10% +$1.34M 0.02% 1024
2016
Q4
$7.77M Buy
173,342
+8,894
+5% +$399K 0.01% 1440
2016
Q3
$9.19M Buy
164,448
+13,020
+9% +$727K 0.01% 1231
2016
Q2
$7.57M Buy
151,428
+14,802
+11% +$740K 0.01% 1264
2016
Q1
$6.27M Buy
136,626
+20,069
+17% +$921K 0.01% 1368
2015
Q4
$7.18M Buy
116,557
+13,814
+13% +$851K 0.01% 1261
2015
Q3
$5.72M Buy
102,743
+41,495
+68% +$2.31M 0.01% 1379
2015
Q2
$3.74M Buy
61,248
+29,946
+96% +$1.83M 0.01% 1737
2015
Q1
$1.81M Buy
31,302
+4,438
+17% +$256K ﹤0.01% 2109
2014
Q4
$1.55M Buy
+26,864
New +$1.55M ﹤0.01% 2153